These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21116322)

  • 1. Non-immune interventions to protect kidney allografts in the long term.
    Cravedi P; Perico N; Remuzzi G
    Kidney Int Suppl; 2010 Dec; (119):S71-5. PubMed ID: 21116322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
    Schwarz C; Regele H; Huttary N; Wahrmann M; Exner M; Nagy-Bojarsky K; Kletzmayr J; Hörl WH; Böhmig GA
    Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive treatment in renal transplant patients--is there a role for ACE inhibitors?
    Hausberg M; Kosch M; Hohage H; Suwelack B; Barenbrock M; Kisters K; Rahn KH
    Ann Transplant; 2001; 6(4):31-7. PubMed ID: 12035456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-immunologic intervention in chronic allograft nephropathy.
    Arias M; Fernández-Fresnedo G; Rodrigo E; Ruiz JC; González-Cotorruelo J; Gómez-Alamillo C
    Kidney Int Suppl; 2005 Dec; (99):S118-23. PubMed ID: 16336564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-grade proteinuria and microalbuminuria in renal transplantation.
    Halimi JM
    Transplantation; 2013 Jul; 96(2):121-30. PubMed ID: 23435457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association Between Renin-Angiotensin System Blockade and Long-term Outcomes in Renal Transplant Recipients: The Wisconsin Allograft Recipient Database (WisARD).
    Shin JI; Palta M; Djamali A; Kaufman DB; Astor BC
    Transplantation; 2016 Jul; 100(7):1541-9. PubMed ID: 26566058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic renal allograft dysfunction: risk factors, immunology and prevention.
    Fadili W; Habib Allah M; Laouad I
    Arab J Nephrol Transplant; 2013 Jan; 6(1):45-50. PubMed ID: 23282234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.
    Kreis HA; Ponticelli C
    Transplantation; 2001 Jun; 71(11 Suppl):SS5-9. PubMed ID: 11583489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smoking Is Related to Postoperative Pulmonary Complications and Graft Outcomes in Renal Transplant Patients.
    Er Dedekargınoğlu B; Ulubay G; Küpeli E; Kırnap M; Öner Eyüboğlu F; Haberal M
    Exp Clin Transplant; 2016 Nov; 14(Suppl 3):87-90. PubMed ID: 27805521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic allograft dysfunction: role of immunosuppressive treatment].
    Comai G; La Manna G; Feliciangeli G; Liviano D'Arcangelo G; Ferri A; Ubaldi G; Scolari MP; Stefoni S
    G Ital Nefrol; 2008; 25 Suppl 44():S48-S52. PubMed ID: 19048586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin Inhibitor-Sparing Strategies in Renal Transplantation: Where Are We? A Comprehensive Review of the Current Evidence.
    Camilleri B; Bridson JM; Halawa A
    Exp Clin Transplant; 2016 Oct; 14(5):471-483. PubMed ID: 27213490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperfiltration nephropathy as a cause of late graft loss in renal transplantation.
    Modlin C; Goldfarb D; Novick AC
    World J Urol; 1996; 14(4):256-64. PubMed ID: 8873441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic allograft nephropathy.
    Najafian B; Kasiske BL
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):149-55. PubMed ID: 18277147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive treatment and progression of histologic lesions in kidney allografts.
    Morales JM
    Kidney Int Suppl; 2005 Dec; (99):S124-30. PubMed ID: 16336565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identifying the specific causes of kidney allograft loss: A population-based study].
    Lohéac C; Aubert O; Loupy A; Legendre C
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S39-S50. PubMed ID: 29606262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase in proteinuria >200 mg/g after late rejection is associated with poor graft survival.
    Djamali A; Samaniego M; Torrealba J; Pirsch J; Muth BL
    Nephrol Dial Transplant; 2010 Apr; 25(4):1300-6. PubMed ID: 19934095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of transplant quality on chronic allograft nephropathy.
    Timsit MO; Yuan X; Floerchinger B; Ge X; Tullius SG
    Kidney Int Suppl; 2010 Dec; (119):S54-8. PubMed ID: 21116319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic renal allograft dysfunction (CAD): new frontiers. Introduction.
    Sayegh MH
    Kidney Int Suppl; 2010 Dec; (119):S1. PubMed ID: 21116309
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.